[Severe Covid-19 comprises a self-amplifying loop of inflammation and coagulopathy]

Kristoffer Loo1, Jonas Åkeson2

  • 1läkar-studerande, Lunds universitet.

Lakartidningen
|January 7, 2022
PubMed

Insights

Severe Covid-19 causes vital organ dysfunction and death through immune hyperactivation and blood clotting. Immunomodulation therapy may be most effective when inflammation is high and viral load is decreasing.

Area of Science:

  • Immunology
  • Pathophysiology
  • Critical Care Medicine

Background:

  • Severe COVID-19 is associated with high mortality.
  • Pathophysiological mechanisms include immune hyperactivation, cytokine release, complement deposition, endothelial damage, and thromboembolism.
  • Ventilation-perfusion mismatch due to alveolar exudation and pulmonary thromboembolism is a primary cause of death.

Purpose of the Study:

  • To elucidate the complex pathophysiological processes in severe COVID-19.
  • To identify optimal timing for immunomodulatory therapies.

Main Methods:

  • Review of pathophysiological self-amplifying loops in severe COVID-19.
  • Analysis of factors contributing to vital organ dysfunction and mortality.
  • Evaluation of the role of inflammation and viral load in therapeutic efficacy.

Main Results:

  • Self-amplifying loops involving innate immunity, cytokines, complement, and coagulation drive organ damage.
  • Pulmonary thromboembolism and ventilation-perfusion mismatch are key lethal events.
  • Therapeutic immunomodulation is suggested to be safer and more effective later in the disease course.

Conclusions:

  • Understanding the intricate interplay of inflammation and coagulation is crucial for managing severe COVID-19.
  • Timing of immunomodulatory interventions, balancing viral load and inflammatory response, is critical for patient outcomes.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
56
Inflammation01:38

Inflammation

Overview
56.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
914
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.9K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
678